The FDA will begin promoting computer-based and lab-grown drug testing models to reduce the cost, time, and ethical burden of drug testing.

AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

UAV Corp. (OTC: UMAV) announced today that its subsidiary, Skyborne Technology, will conduct a scheduled inflation test of ...

The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...

Get Instant Summarized Text (Gist) The FDA is transitioning from animal testing to more human-relevant methods in drug development, particularly for monoclonal antibody therapies. This approach ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

The FDA will use computer modeling and artificial intelligence to predict a drug’s behavior and promote the use of lab-grown human organoids. HealthDay News — The US Food and Drug ...

The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods that it hopes will be more relevant to human physiology.

The trial phase will begin with 50 autonomous vehicles in the coming months, setting the stage for the public launch in 2026 ...

Some states have already moved to restrict some synthetic dyes and the FDA banned Red 3 from the nation’s food supply.